Gallery
Liver, C1-5-D
Carotid Stenosis B-Flow™, ML6-15-D
Breast Lesion, ML6-15-D
Neonatal Head Power Doppler Imaging, C3-10-D
Intraoperative Liver Lesion, L3-9i-D
Liver Shear Wave Elastography, C1-6-D
Abdominal Aortic Aneurysm, C1-6-D
Breast Lesion, ML6-15-D
Neonatal Head B-Flow, C3-10-D
Volume Navigation 3D GPS Markers, C1-6VN-D
Hepatic Focal Nodular Hyperplasia, 9L-D
Carotid Color Flow, 9L-D
Breast, ML6-15-D
Neonatal Spine, ML6-15-D
Thyroid Nodule B-Steer+, ML6-15-D
Pediatrics
Education and Training
Services and Support
Ultrasound IT
Resources
LOGIQ E9 Volume Navigation Overview
LOGIQ E9 Volume Navigation Needle Tracking Benefits
LOGIQ E9 Needle Tracking Overview
GE Healthcare LOGIQ E9 Fusion
LOGIQ E9 Elastography
LOGIQ E9 Volume Navigation Image Examples
LOGIQ E9 GPS Overview
LOGIQ E9 Needle Tracking Clinical Impact
LOGIQ E9 Query Retrieve
LOGIQ E9 Scan Assistant
Related
Supporting Materials
LOGIQ E9 XDclear 2.0 Probe GuideProductComponents.SupportingMaterials.Download
†As compared to GE's LOGIQ E9 with XDclear ultrasound system
1. KLAS Performance Report: Ultrasound 2014, Saving Time and Money with Workflow Automation.
2. The LOGIQ E9 is designed for compatibility with most commercially available ultrasound contrast agents. Availability of these agents is subject to government regulation and approval. Contrast imaging should be performed within the approved indications for use of the contrast agent used in the exam.
LOGIQ, XDclear and B-Flow are trademarks of the General Electric Company.
1. KLAS Performance Report: Ultrasound 2014, Saving Time and Money with Workflow Automation.
2. The LOGIQ E9 is designed for compatibility with most commercially available ultrasound contrast agents. Availability of these agents is subject to government regulation and approval. Contrast imaging should be performed within the approved indications for use of the contrast agent used in the exam.
LOGIQ, XDclear and B-Flow are trademarks of the General Electric Company.